Build your sample management strategy for the 21st century
Proper sample management, including biobanking, storage, and transport, is the cornerstone of bringing a successful drug or therapeutic to market. Traditionally, these processes have been manual – but with recent advancements in automation, the production of new therapies has been transformed by enabling greater workflow efficiency and speed. With the next generation of therapeutics, such as cell and gene therapies, however, the industry faces new challenges – biological products and specimens require colder and more stringent storage environments compared to small molecules, complicating how they are managed in the lab and the clinic.
As a veteran of the pharmaceutical industry and an expert in drug discovery, Sue Holland-Crimmin, Ph.D., has witnessed—and helped bring about—a revolution in sample and material management. In this eBook, Dr. Holland-Crimmin discusses the lessons learned in drug development and how pharmaceutical and biotech companies can address key challenges in sample management.
What you’ll learn about:
- How automation has enabled labs to scale up production and sample handling
- The impact of automation in developing novel drugs and therapeutics, such as cell and gene therapies
- Challenges associated with biological sample management and the role automation can play in addressing these challenges
- Key considerations for integrating automation into your sample management strategy
About Sue Holland-Crimmin, Ph.D.
Sue Holland-Crimmin, Ph.D.
Scientific Consultant
Dr. Holland-Crimmin recently retired as the vice president of a global department at GlaxoSmithKline, where she was responsible for the quality and rigor of R&D supply chains. A recognized expert in automation, she has in-depth knowledge and experience in medicine discovery. Dr. Holland-Crimmin holds a degree in microbiology, a Ph.D. in biochemistry & molecular biology, and is a trained Lean Sigma facilitator. She is a board member and fellow of the Society for Laboratory Automation and Screening (SLAS) and has served as Editor of the Journal of Biomolecular Screening and the Journal of Laboratory Automation. Dr. Holland-Crimmin currently runs a consultancy company specializing in sample management, automation, and drug discovery.
Complete the form to download the eBook.